Gene transfer and therapy clinical trials – update. Part I: Countries, Diseases, Clinical trial phases, Routes of administration

✍ Scribed by Thomas Valère

• Publisher: John Wiley and Sons
• Year: 1999
• Tongue: English
• Weight: 183 KB
• Volume: 1
• Category: Article
• ISSN: 1099-498X
• DOI: 10.1002/(sici)1521-2254(199901/02)1:1<71::aid-jgm10>3.0.co;2-a

✦ Synopsis

Part I*: Countries, Diseases, Clinical trial phases, Routes of administration

Countries

Countries where clinical trials are being performed or have been approved

Gene therapy trials have now been initiated on all ®ve continents but the large majority of trials are being performed in the USA which accounts for approximately 75% of the world's trials and patients. Trials are also under way in Canada.

Europe, including Eastern European countries such as Poland, has been initiating trials at an increasing rate since 1995.

China inaugurated Asian gene therapy in 1991, followed in 1995 by Japan, and in April 1997 by Korea. Two trials have also been started in Israel and two in Singapore.

In Egypt, a team is conducting a clinical trial in oncology since 1996. This is the only trial currently being performed in Africa.

Australia (2) and New Zealand (1) have also initiated gene therapy clinical trials.

The information presented in this article is derived from the clinical trials database of The Journal of Gene Medicine website (http:// www.wiley.co.uk/genmed). You are invited to visit the site for regularly updated statistics, charts, tables and detailed information on individual trials. Permission to use the charts and tables from the site for publications or public presentations should be addressed to